Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$766M |
| 2 |
Adobe
ADBE
|
$529M |
| 3 |
Merck
MRK
|
$463M |
| 4 |
Tesla
TSLA
|
$359M |
| 5 |
AGN
Allergan plc
AGN
|
$339M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$714M |
| 2 |
Gilead Sciences
GILD
|
$600M |
| 3 |
Perrigo
PRGO
|
$585M |
| 4 |
EMC
EMC CORPORATION
EMC
|
$448M |
| 5 |
Morgan Stanley
MS
|
$423M |
Sector Composition
| 1 | Healthcare | 17.95% |
| 2 | Consumer Discretionary | 15% |
| 3 | Communication Services | 10.58% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
